Barbara Pro

Barbara Pro is an Associate Professor in the Nursing - Undergraduate department at Thomas Jefferson University's College of Nursing. With an extensive publication record spanning over two decades, Dr. Pro has established herself as a prominent researcher in lymphoma, particularly focusing on T-cell lymphomas, CAR-T cell therapy, and novel treatment approaches for hematologic malignancies. Her work bridges nursing and medical oncology, contributing significantly to clinical practice guidelines and treatment protocols.

Dr. Pro's research interests center on lymphoma pathogenesis, treatment strategies for peripheral T-cell lymphomas, and the application of novel therapeutics in hematologic malignancies. Her work spans from basic science investigations of lymphoma biology to large-scale clinical trials and consensus guideline development. She has been particularly active in studying cutaneous T-cell lymphoma, mantle cell lymphoma, and the application of immunotherapies in lymphoma treatment. Her research has helped shape current treatment paradigms through numerous publications in high-impact journals and contributions to major clinical guidelines.

Analysis of Dr. Pro's recent publications reveals a strong focus on clinical trials evaluating novel combination therapies, particularly in T-cell lymphomas. Her work increasingly addresses health disparities in lymphoma treatment outcomes and the application of precision medicine approaches. She has been instrumental in developing treatment guidelines through organizations like NCCN and has contributed to major cooperative group studies examining CAR-T cell therapy, stem cell transplantation, and targeted agents in lymphoma.

Dr. Pro has served as a principal or co-investigator on numerous clinical trials and has been an active contributor to major lymphoma treatment guidelines, including those from the National Comprehensive Cancer Network (NCCN). Her collaborative approach is evident in the extensive list of co-authors spanning multiple institutions and specialties.

While specific laboratory affiliations aren't detailed in the provided information, Dr. Pro's extensive clinical trial work suggests strong connections with clinical research teams and oncology practice networks. Her research spans both academic medical centers and community practice settings, reflecting a commitment to translating research findings into real-world clinical practice.